Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives

Potent, cell-permeable, and subtype-selective sialyltransferase inhibitors represent an attractive family of substances that can potentially be used for the clinical treatment of cancer metastasis. These substances operate by specifically inhibiting sialyltransferase-mediated hypersialylation of cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Ser John Lynon P., Fu, Chih-Wei, Li, Wen-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470674/
https://www.ncbi.nlm.nih.gov/pubmed/34577144
http://dx.doi.org/10.3390/molecules26185673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470674/
https://www.ncbi.nlm.nih.gov/pubmed/34577144
http://dx.doi.org/10.3390/molecules26185673

Ejemplares similares